Cargando…

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics

Detalles Bibliográficos
Autor principal: Timchenko, Lubov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570427/
https://www.ncbi.nlm.nih.gov/pubmed/36233257
http://dx.doi.org/10.3390/ijms231911954
_version_ 1784810103804788736
author Timchenko, Lubov
author_facet Timchenko, Lubov
author_sort Timchenko, Lubov
collection PubMed
description
format Online
Article
Text
id pubmed-9570427
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95704272022-10-17 Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics Timchenko, Lubov Int J Mol Sci Editorial MDPI 2022-10-08 /pmc/articles/PMC9570427/ /pubmed/36233257 http://dx.doi.org/10.3390/ijms231911954 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Timchenko, Lubov
Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
title Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
title_full Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
title_fullStr Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
title_full_unstemmed Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
title_short Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
title_sort myotonic dystrophy: from molecular pathogenesis to therapeutics
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570427/
https://www.ncbi.nlm.nih.gov/pubmed/36233257
http://dx.doi.org/10.3390/ijms231911954
work_keys_str_mv AT timchenkolubov myotonicdystrophyfrommolecularpathogenesistotherapeutics